MAVIRET

Abbvie Corporation🇨🇦 Health Canada

Approval Id: b2d2d4a4d677809a
Drug Approval Canada Name: MAVIRET
Product Name: MAVIRET
Status: Marketed
Status Date: 2017-09-13
Original Market Date: 2017-09-13
Din: 02467550
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 08:18.40.24
Atc Original: J05AP57 GLECAPREVIR AND PIBRENTASVIR
Atc Name: j 05 ap 57
Aig Number: 0259390001
Company Name: Abbvie Corporation
Company Address: 8401 Trans-Canada Highway, Saint-Laurent, Quebec, Canada, H4S 1Z1
Company Detail Path: /organization/abbvie-corporation

GLECAPREVIR

100 MG

PIBRENTASVIR

40 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

b2d2d4a4d677809a

Type

Standard